Review Article
The Nicotinic Acetylcholine Receptor as a Target for Antidepressant Drug Development
Table 1
Evidence for MEC/S-MEC in mouse models of depression.
| Study | Compound(s) | MEC/s-MEC dose | Results |
| Popik et al. [35] | MEC + CTP MEC + IMI | 0.025 mg/kg | Improved FST |
| Rabenstein et al. [36] | MEC | 1 mg/kg | Improved FST and TST |
|
Caldarone et al. [37] | MEC | 0.50, 0.75, or 1.0 mg/kg | Improved FST/TST | MEC + AMI | | Further improved FST/TST |
| Andreasen et al. [38] | MEC | 3 or 10 mg/kga | Improved FST/TST |
|
Andreasen and Redrobe [20] | MEC + CTP | 1, 3 mg/kg | No effect on FST/TST | MEC + REB | | |
| Mineur et al. [39] | MEC | 1 mg/kg | Improved FST/TST |
| Lippiello et al. [40] | S-MEC | 3 mg/kg | Improved FST |
|
|
Notes: a1–10 mg/kg doses tested, and only doses at 3 and 10 mg/kg with improved FST/TST. Abbreviations: MEC: mecamylamine; CTP: citalopram; IMI: imipramine; AMI: amitriptyline: REB: reboxetine; S-MEC: s-mecamylamine; FST: forced swim test; TST: tail suspension test.
|